InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (1 ops.)
Explore the detailed record of transactions filed by MARK MILLER, Directeur Exécutif Affaires Médicales. Officer active across 1 companies, notably BIOMERIEUX. Aggregated, 4 disclosures have been logged. Total volume traded: €185k. The latest transaction was disclosed on 4 September 2023 — Cession. Regulator: AMF. All data is openly available.
Declarations4 total
€150,4821,567 shares@ €96.0320.0012% mcap81.2% of flow
ActionEuronext Paris
2023DD926508·
03,625 shares0
ActionHors plateforme de négociation
2023DD926507·
US$34,746300 shares@ US$115.820.0003% mcap18.8% of flow
ActionHors plateforme de négociation
2023DD916808·
Ideal exit: 19 Mar 2024 (T+270)
06,052 shares0
ActionAcquisition d'actions gratuite
2022DD824952·
Ideal exit: 23 Nov 2022 (T+270)
4 of 4 declarations
About MARK MILLER
Mark Miller is the Executive Vice President, Chief Medical Officer at BIOMERIEUX. He oversees the medical and strategic operations of the company, playing a key role in developing diagnostic solutions. His expertise in the healthcare sector is essential for innovation and growth.
